|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7048 | (2006.01) |
| A61K 31/135 | (2006.01) | ||
| A61K 31/365 | (2006.01) | ||
| A61P 3/04 | (2006.01) |
| (11) | Patento numeris | 2827874 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13710411.3 |
| Europos patento paraiškos padavimo data | 2013-03-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/055671 |
| Data | 2013-03-19 |
| (87) | Numeris | WO 2013/139777 |
| Data | 2013-09-26 |
| (30) | Numeris | Data | Šalis |
| 12160377 | 2012-03-20 | EP |
| (72) |
MAYOUX, Eric Williams , DE
GREMPLER, Rolf , DE
KLEIN, Thomas , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND ANTIOBESITY DRUG |
| PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND ANTIOBESITY DRUG |